Science
Have you tried psychedelics? You have until next Friday, May 16, to take part in a Global Survey, available in 18 languages
Michigan State University in the United States of America (USA) is conducting a global survey on psychedelics among adults over the age of 21 who have had experience with these substances. This is the largest study on the use of psychedelics to date, and is available in 18 languages and accessible in every country in the world. If you have had any experience with psychedelics, you can participate until next Friday, May 16, by this link.
The launch of the Global Psychedelic Survey 2025 (GPS 2025) represents a unique opportunity for adults aged 21+ from countries around the world to contribute to the largest international study of psychedelic use to date.
Based at the University of Michigan, the research aims to collect experiences from people who use psychedelic substances such as LSD, ibogaine, MDMA and psilocybin, among others.
“We believe that the true experts on psychedelics are the people who have tried them. Sharing their lived experiences and knowledge can help reduce stigma and guide public policy to ensure safer, more informed and legal access for both medicinal and non-medicinal uses,” said Philippe Lucas, Director of Research and Safe Access at MAPS (Multidisciplinary Association for Psychedelic Studies) and the University of Michigan Psychedelic Center.
Philippe Lucas is also coordinating MJP2, a multi-site Phase 2 study of cannabis for treating PTSD in 320 US veterans, as well as supporting research into MDMA for treating war-related trauma/PTSD in conflict zones such as the Balkans, Ukraine, the Middle East and Africa.
GPS 2025 is available globally in 18 languages and will be available online exclusively until May 16, 2025. DIt takes between 30 and 40 minutes to complete, depending on each person’s unique experiences. “This research can significantly contribute to shaping public policy and guiding future research in the years to come,” Philippe Lucas told CannaReporter®.
Who can participate?
Adults 21 or older who have consumed at least one psychedelic substance. Substances may include, but are not limited to, psilocybin-containing mushrooms, LSD (lysergic acid diethylamide), MDMA (3,4-methylenedioxymethamphetamine), ketamine, ayahuasca, and nitrous oxide.
What can participants expect?
The survey should take 30 to 40 minutes to complete and participation is anonymous and voluntary.
According to the team conducting the survey, the GPS already has more than 5.500 responses and includes some surprises, such as the high number of Italian, Japanese, Hebrew and Latin American participants, in addition to representing some opportunities for greater reach in Germany, Portugal, Greece and Turkey.
While all responses will be completely anonymous, participants will have the opportunity to enter a prize draw for 1 of the 15 Amazon Gift Cards worth $100, by voluntarily providing an email address at the end of the survey. However, it is not mandatory to provide any contact information to participate in the survey.
Participate here: https://umich.qualtrics.com/jfe/form/SV_cGz7Zgf9V2e3pnU
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
RAW Founder Josh Kesselman Buys High Times Magazine for $3,5 Million
Josh Kesselman, founder of the world famous RAW rolling papers, has just purchased the rights and intellectual property of High...
4th edition of Hemp Fiber Lab will take place next weekend in Sintra
The 7 irmãs collective, in collaboration with Sensihemp, organizes the 4th Hemp Fiber Lab at Quinta dos 7 nomes,...
2nd edition of the Binóide Festival celebrates cannabis culture at Village Underground, in Lisbon
The second edition of the Binóide Festival will take place on June 29th, at Village Underground, in Lisbon, and will bring together...
Legalization turns Germany into a cannabis hotspot: Mary Jane becomes the world's largest cannabis fair for the first time
Berlin, June 16, 2025 – About a year after the partial legalization by the government coalition of the “traffic light”,...
Anar Artur: “Industrial hemp needs fresh and innovative solutions”
At 37, Anar Artur is one of the most committed voices in the promotion of hemp in Mongolia. With a career spanning...
The right to health and access to medicinal cannabis in Portugal: an unfulfilled constitutional promise
On May 31, 2025, the Cannabis March took place in Lisbon, where people from all over...
Berlin heats up for Cannabis Week with Mary Jane, Business of Cannabis B2B Sessions and CB Club x EmpowHer Meetup
The German capital will become the epicentre of the European cannabis scene next week, with a series of events...
CBD and CBDV demonstrate potent antifungal activity in peer-reviewed study
A study published in the journal PLOS Neglected Tropical Diseases confirms that cannabidiol (CBD) and cannabidivarin (CBDV) have potent...
Lighting the Way Forward: Why EMEA Growers Are Rethinking Retrofits
A new era of grow efficiency begins with smarter lighting decisions. As growers grow...
Systematic review addresses risks and benefits of medicinal cannabis in mental health
A systematic review entitled “The differential effects of medicinal cannabis on mental health” carried out by researchers from Erasmus University in...
